ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/23/2026
Back to search
Official data from USPTO
REVANIX BIOMEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
04/24/2026
Trademark type
Combined
Nice classes
37
Filing date
08/14/2017
Registration date
03/13/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/12/2024
Last transaction
04/24/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
04/03/2017
First use in commerce
04/03/2017
Drawing code
5
Owner type
16
Owner location
CORAL SPRINGS, FL, US
Examiner
SMITH, BRIDGETT G
Current location
FILE DESTROYED
Mark description
The mark consists of the words "REVANIX BIOMEDICAL" in a stylized font.
Holders and representatives
Holders
Revanix Biomedical LLC
Representatives
Francis John Ciaramella, Esquire RICK RUZ, PLLC
Technical classification
Nice Classes
Class 37
Vienna Codes
No Vienna codes available.
Goods and services
Class 37
Repair services for medical diagnostic imagingclinical and biomedical equipment
Publications
History of USPTO decisions and trademark events.
15 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/12/2024
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/12/2024
ES8R
TEAS SECTION 8 RECEIVED
03/13/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/13/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/17/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
03/13/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/26/2017
PUBO
PUBLISHED FOR OPPOSITION
12/26/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/22/2017
DOCK
ASSIGNED TO EXAMINER
11/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/19/2017
NWAP
NEW APPLICATION ENTERED
08/17/2017
Continuous trademark protection
Get notified about every new filing that threatens REVANIX BIOMEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.